Format

Send to

Choose Destination
Vaccine. 2006 Jul 17;24(29-30):5755-61. Epub 2006 May 4.

Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.

Author information

1
Department of Microbiology, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216, United States.

Abstract

The effect of priming and boosting with pspA/EF5668 and purified recombinant PspA/EF5668 was examined. With this strategy CBA/N mice were protected against fatal challenge with Streptococcus pneumoniae EF5668. Anti-PspA antibody titers were elevated, and Western analysis with the immune serum demonstrated cross-reactivity with PspA from several different pneumococcal isolates, representing different PspA clades. Immune serum localized cross-reactive epitopes to the alpha-helical domain of PspA/Rx1 and PspA/EF5668. We demonstrated that DNA/protein prime-boost immunizations can enhance protective immunity against pneumococcal challenge.

PMID:
16759765
DOI:
10.1016/j.vaccine.2006.04.046
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center